We have generated by reverse genetics H3N8 CIVs containing truncated or a deleted NS1 protein. NS1 mutant H3N8 CIVs replicated efficiently in MDCK cells, important for vaccine production. H3N8 CIV with mutated NS1 are attenuated in vivo (mice) or ex vivo (canine tracheal explants). NS1 mutant viruses confer complete protection against challenge with WT H3N8 CIV. This is the first description of a LAIV for the prevention and control of H3N8 CIV in dogs.